LS60.F Clinical Laserthermia Systems AB (publ)

Healthcare Medical Devices Frankfurt Exchange
0.1122 EUR
Close of Nov 12, 2026
0.1050 0.8000
Market cap
EUR 5.44M
P/E
-
P/B
1.23x
ROE
-81.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is LS60.F undervalued?

Graham number

The Graham number of Clinical Laserthermia Systems AB (publ) cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Clinical Laserthermia Systems AB (publ) fundamental analysis

No fundamental analysis for Clinical Laserthermia Systems AB (publ) yet.

Clinical Laserthermia Systems AB (publ) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Clinical Laserthermia Systems AB (publ)

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, a…

Full company profile